Australian Government: Australian Institute of Health and Welfare METeOR Home Page

6.1, 6.2, 6.3 Number of PBS prescriptions dispensed for asthma medicines per 100,000 people, 2013–14

Identifying and definitional attributes

Metadata item type:Help on this termIndicator
Indicator type:Help on this termIndicator
Short name:Help on this termAsthma medicines dispensing, 2013-14
METeOR identifier:Help on this term611645
Registration status:Help on this termNational Health Performance Authority (retired), Retired 01/07/2016
Australian Commission on Safety and Quality in Health Care, Standard 23/11/2016
Description:Help on this term

Number of prescriptions dispensed for asthma medicines per 100,000 people, age standardised. Data are disaggregated by the area in which the person lives.

Indicator set:Help on this termAustralian Atlas of Healthcare Variation National Health Performance Authority (retired), Retired 01/07/2016
Australian Commission on Safety and Quality in Health Care, Standard 23/11/2016

Collection and usage attributes

Population group age from:Help on this term

3 to 19 years
20 to 44 years
45 years and over

Computation description:Help on this term

 

Presented as a number per 100,000 people, age standardised, by Statistical Area Level 3.

Analysis by Statistical Area Level 3 (SA3) is based on postcode of usual residence of the patient which is based on the patient's Medicare enrolment postcode on the date the prescription was dispensed.

SA3s where the total population was less than 2,500 or where the population of interest was less than 200 are excluded.

Suppression protocol for calculating age standardised rates:

 

Numerator Total prescriptions dispensed were less than 20 (unrounded data)
Denominator ERP for one or more five year age groups was less than 30

For the population group 3 to 19 years, the following age groups were used for calculating age standardised rates: 3-9, 10-14, 15-19.

Computation:Help on this term

100,000 x (Numerator ÷ Denominator), age standardised

For more information about age-standardisation, see

http://meteor.aihw.gov.au/content/index.phtml/itemId/327276

Numerator:Help on this term

Number of PBS prescriptions dispensed for asthma medicines in 2013-14.

Numerator data elements:Help on this term
Data Element / Data SetPharmaceutical Benefits Scheme (PBS) prescription—PBS item prescribed, code NN[NNN]A
NMDS / DSS
Pharmaceutical Benefits Scheme (PBS) state/territory data extract 2013-14
Guide for use

Data source type: Administrative by-product data

 

PBS code Description
01034K TERBUTALINE–Injection containing terbutaline sulfate 500 micrograms in 1 mL
01099W SALBUTAMOL–Capsule containing powder for oral inhalation 200 micrograms (as sulfate) (for use in Ventolin Rotahaler)
01103C SALBUTAMOL–Oral solution 2 mg (as sulfate) per 5 mL, 150 mL
01252X TERBUTALINE–Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 200 doses
01542E IPRATROPIUM–Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30
02000G SALBUTAMOL–Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
02001H SALBUTAMOL–Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30
02003K SALBUTAMOL–Nebuliser solution 5 mg (as sulfate) per mL, 30 mL
02065Q BUDESONIDE–Nebuliser suspension 500 micrograms in 2 mL single dose units, 30
02066R BUDESONIDE–Nebuliser suspension 1 mg in 2 mL single dose units, 30
02070Y BUDESONIDE–Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses
02071B BUDESONIDE–Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses
02072C BUDESONIDE–Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses
02614N THEOPHYLLINE–Oral solution 133.3 mg per 25 mL, 500 mL
02634P THEOPHYLLINE–Tablet 250 mg (sustained release)
02817G TERBUTALINE–Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 100 doses
02827T FLUTICASONE + EFORMOTEROL–Pressurised inhalation containing fluticasone propionate 50 micrograms with eformoterol fumarate dihydrate 5 micrograms per dose, 120 doses
02866W BUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses, 2
02867X BUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 50 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses, 2
02878L CROMOGLYCATE–Capsule containing powder for oral inhalation containing sodium cromoglycate 20 mg (for use in Intal Spinhaler or Intal Halermatic)
02938P BUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 100 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses, 2
03491R TERBUTALINE–Injection containing terbutaline sulfate 500 micrograms in 1 mL
03495Y SALBUTAMOL–Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
03496B SALBUTAMOL–Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

03497C

SALBUTAMOL–Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

05134F

INDACATEROL–Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler)
05137J INDACATEROL–Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler)
08136F EFORMOTEROL–Capsule containing powder for oral inhalation containing eformoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer)
08141L SALMETEROL–Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses
08147T FLUTICASONE–Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses
08148W FLUTICASONE–Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses
08149X FLUTICASONE–Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses
08230E THEOPHYLLINE–Tablet 200 mg (sustained release)
08231F THEOPHYLLINE–Tablet 300 mg (sustained release)
08238N IPRATROPIUM–Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30
08239P EFORMOTEROL–Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 6 micrograms per dose, 60 doses
08240Q EFORMOTEROL–Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses
08288F SALBUTAMOL–Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
08334P CROMOGLYCATE–Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC-free formulation)
08345F FLUTICASONE–Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation)
08346G FLUTICASONE–Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation)
08354Q SALBUTAMOL–Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
08365G NEDOCROMIL–Pressurised inhalation containing nedocromil sodium 2 mg per dose, 112 doses (CFC-free formulation)
08406K BECLOMETHASONE–Pressurised inhalation containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation)
08407L BECLOMETHASONE–Pressurised inhalation containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation)
08408M BECLOMETHASONE–Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation)
08409N BECLOMETHASONE–Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation)
08430Q FLUTICASONE + SALMETEROL–Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
08431R FLUTICASONE + SALMETEROL–Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
08432T FLUTICASONE + SALMETEROL–Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
08516F FLUTICASONE–Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation)
08517G FLUTICASONE + SALMETEROL–Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)
08518H FLUTICASONE + SALMETEROL–Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)
08519J FLUTICASONE + SALMETEROL–Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)
08625Y BUDESONIDE + EFORMOTEROL–Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses
08627C MONTELUKAST–Tablet, chewable, 4 mg (as sodium)
08628D MONTELUKAST–Tablet, chewable, 5 mg (as sodium)
08671J IPRATROPIUM–Pressurised inhalation containing ipratropium bromide 21 micrograms per dose, 200 doses (CFC-free formulation)
08750M BUDESONIDE + EFORMOTEROL–Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2
08767K CROMOGLYCATE–Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC-free formulation)
08796Y BUDESONIDE + EFORMOTEROL–Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses
08853Y CICLESONIDE–Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation)
08854B CICLESONIDE–Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation)
09745X OMALIZUMAB–Powder for injection 150 mg with diluent
09746Y OMALIZUMAB–Powder for injection 150 mg with diluent
10007Q FLUTICASONE + EFORMOTEROL–Pressurised inhalation containing fluticasone propionate 125 micrograms with eformoterol fumarate dihydrate 5 micrograms per dose, 120 doses
10008R FLUTICASONE + EFORMOTEROL–Pressurised inhalation containing fluticasone propionate 250 micrograms with eformoterol fumarate dihydrate 10 micrograms per dose, 120 doses
10015D BUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 100 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses
10018G BUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses
10024N BUDESONIDE + EFORMOTEROL–Pressurised inhalation containing budesonide 50 micrograms with eformoterol fumarate dihydrate 3 micrograms per dose, 120 doses
10059K GLYCOPYRRONIUM–Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler)

Denominator:Help on this term

Total population of age group

Denominator data elements:Help on this term
Data Element / Data SetPerson—estimated resident population of Australia, total people N[N(7)]
Data Source
ABS Estimated resident population (total population)
Guide for use

ABS Estimated resident population as at June 2001

Data source type: Census based plus administrative by-product data


Disaggregation:Help on this term

Statistical Area Level 3, which have been derived from Postcode—Australian (person)

  • Statistical Area Level 3 (SA3s) are geographic areas defined in the ABS Australian Statistical Geography Standard (ASGS). The aim of SA3s is to create a standard framework for the analysis of ABS data at the regional level through clustering groups of SA2s that have similar regional characteristics. There are 333 spatial SA3s covering the whole of Australia without gaps or overlaps. They are designed to provide a regional breakdown of Australia. SA3s generally have a population of between 30,000 and 130,000 people. There are approximately 50 with fewer than 30,000 people and 35 with more than 130,000 as at 30 June 2011. For further information see the ABS publication, Australian Statistical Geography Standard (ASGS): Volume 1 – Main Structure and Greater Capital City Statistical Areas, July 2011 (cat. no. 1270.0.55.001).
Disaggregation data elements:Help on this term
Data Element / Data SetAddress—Australian postcode, Australian postcode code (Postcode datafile) {NNNN}
NMDS / DSS
COMPLETE - Pharmaceutical Benefits Scheme (PBS) Pharmacy claim script detail
Guide for use

Postcode is based on the patient's Medicare enrolement postcode on the date the prescription was dispensed.

GPO postcodes 2001, 2124, 3001, 4001, 5001, 6843 excluded from the SA3 analysis but included in state/territory and national level analysis.

Data source type: Administrative by-product data

Used for disaggregation by Statistical Area Level 3.


Data Element / Data SetAddress—statistical area, level 3 (SA3) code (ASGS 2011) NNNNN
Data Element / Data SetPerson—age, total years N[NN]
NMDS / DSS
COMPLETE - Pharmaceutical Benefits Scheme (PBS) Pharmacy claim script detail
Guide for use

Age of the person is based on the patient's Medicare enrolment date of birth and the date the prescription was dispensed.

Data is disaggregated by the following age groups:

  • 3 to 19 years
  • 20 to 44 years
  • 45 and over.

Representational attributes

Representation class:Help on this termRate
Data type:Help on this termInteger
Unit of measure:Help on this termService event
Format:Help on this term

NN[NNNN]

Data source attributes

Data sources:Help on this term
Data SourceABS Estimated resident population (total population)
Frequency
Quarterly
Quality statement
ABS Estimated resident population (total population), QS
Data custodian
Australian Bureau of Statistics

Accountability attributes

Reporting requirements:Help on this term

Australian Commission of Safety and Quality in Health Care's Atlas of Healthcare Variation, released November 2015

Organisation responsible for providing data:Help on this term

Department of Health

Accountability:Help on this term

Australian Commission of Safety and Quality in Health Care

Source and reference attributes

Submitting organisation:Help on this term

National Health Performance Authority

My items Help on this term
Download Help on this term